Mutagenicity and pausing of HIV reverse transcriptase during HIV plus-strand DNA synthesis.
The unusually high frequency of misincorporation by HIV-1 reverse transcriptase (HIV RT) is likely to be the major factor in the rapid accumulation of viral mutations in AIDS, especially in the env gene. To investigate the ability of HIV RT to copy the env gene, we subcloned an HIV env gene fragment into a single-stranded DNA vector and measured the progression of synthesis by HIV RT. We observed that HIV RT, but not RT from avian myeloblastosis virus, DNA polymerase-alpha or T7 DNA polymerase, pauses specifically at poly-deoxyadenosine stretches within the env gene. The frequency of bypassing the polyadenosine stretches by HIV RT is enhanced by increasing the ratio of enzyme to template. We measured the fidelity of DNA synthesis within a segment of the hypervariable region 1 of the env gene (V-1) containing a poly-deoxyadenosine sequence by repetitively copying the DNA by HIV RT, and then cloning and sequencing the copied fragments. We found that 27% of the errors identified in V-1 sequence were frameshift mutations opposite the poly-adenosine tract, a site where strong pausing was observed. Pausing of HIV RT at the polyadenosine tract could be enhanced by either distamycin A or netropsin, (A-T)-rich minor groove binding peptides. Moreover, netropsin increases the frequency of frameshift mutations in experiments in which HIV RT catalyzes gap filling synthesis within the lacZ gene in double-stranded circular M13mp2 DNA. These combined results suggest that the enhanced mutation frequency may be due to increased pausing at netropsin-modified polyadenosine tracts. Therefore, netropsin and related A-T binding chemicals may selectively enhance frameshift mutagenesis induced by HIV RT and yield predominantly non-viable virus.
Ji
J
J
Joseph Gottstein Memorial Cancer Research Laboratory, Department of Pathology SM-30, University of Washington, Seattle 98195.
Hoffmann
J S
JS
Loeb
L
L
D001482:Base Composition; D001483:Base Sequence; D004279:DNA, Viral / Q000096:biosynthesis*; D004214:Distamycins / Q000494:pharmacology; D015752:Genes, env; D054303:HIV Reverse Transcriptase; D015497:HIV-1 / Q000201:enzymology*; D066298:In Vitro Techniques; D008969:Molecular Sequence Data; D016296:Mutagenesis; D009429:Netropsin / Q000494:pharmacology; D011061:Poly A / Q000378:metabolism; D012194:RNA-Directed DNA Polymerase / Q000378:metabolism*; D013379:Substrate Specificity; D013698:Templates, Genetic; D014779:Virus Replication
D004279:DNA, Viral; D004214:Distamycins; D011061:Poly A; D009429:Netropsin; C030000:stallimycin; D054303:HIV Reverse Transcriptase; D012194:RNA-Directed DNA Polymerase